Charles Theuer Tracon Pharmaceuticals, Inc. (TCON) insider trading activity

Charles Theuer is PRESIDENT AND CEO of Tracon Pharmaceuticals, Inc.. Currently has a direct ownership of 406,417 shares of TCON, which is worth approximately $304,812. The most recent transaction as insider was on Oct 20, 2023, when has been sold 3,500 shares (Common Stock) at a price of $0.13 per share, resulting in proceeds of $455. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 406K

0% 3M change

1.75% 12M change

Total Value Held $304,812

CHARLES THEUER Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Oct 20 2023	BUY Grant, award, or other acquisition	$455 $0.13 p/Share	3,500 Added 0.85%	406,417 Common Stock
Apr 27 2023	BUY Open market or private purchase	$35,250 $0.75 p/Share	47,000 Added 10.53%	399,417 Common Stock
Apr 26 2023	BUY Open market or private purchase	$2,639 $0.66 p/Share	3,999 Added 1.12%	352,417 Common Stock
Apr 20 2023	BUY Grant, award, or other acquisition	$490 $0.14 p/Share	3,500 Added 0.86%	402,917 Common Stock
Mar 01 2023	BUY Open market or private purchase	$7,296 $1.52 p/Share	4,800 Added 1.37%	344,918 Common Stock
Feb 28 2023	BUY Open market or private purchase	$304 $1.52 p/Share	200 Added 0.06%	340,118 Common Stock
Jan 18 2023	BUY Open market or private purchase	$11,016 $1.62 p/Share	6,800 Added 1.96%	339,918 Common Stock

Dec 14 2022	BUY Open market or private purchase	$29,670 $1.29 p/Share	23,000 Added 6.46%	333,118 Common Stock
Nov 18 2022	BUY Open market or private purchase	$19,599 $1.41 p/Share	13,900 Added 4.29%	310,118 Common Stock
Nov 03 2022	BUY Open market or private purchase	$13,984 $1.52 p/Share	9,200 Added 3.01%	296,218 Common Stock
Nov 02 2022	BUY Open market or private purchase	$9,540 $1.59 p/Share	6,000 Added 2.05%	287,018 Common Stock
Oct 07 2022	BUY Open market or private purchase	$8,850 $1.77 p/Share	5,000 Added 1.77%	277,518 Common Stock
Oct 03 2022	BUY Open market or private purchase	$8,350 $1.67 p/Share	5,000 Added 1.8%	272,518 Common Stock
Sep 22 2022	BUY Open market or private purchase	$8,800 $1.76 p/Share	5,000 Added 1.83%	267,518 Common Stock
Jul 22 2022	BUY Open market or private purchase	$8,325 $1.85 p/Share	4,500 Added 1.69%	262,518 Common Stock
Jul 13 2022	BUY Open market or private purchase	$5,520 $1.84 p/Share	3,000 Added 1.15%	258,018 Common Stock
Jul 12 2022	BUY Open market or private purchase	$5,610 $1.87 p/Share	3,000 Added 1.16%	255,018 Common Stock
May 09 2022	BUY Open market or private purchase	$18,500 $1.85 p/Share	10,000 Added 3.82%	252,018 Common Stock
May 06 2022	BUY Open market or private purchase	$4,925 $1.97 p/Share	2,500 Added 1.02%	242,018 Common Stock
Apr 29 2022	BUY Open market or private purchase	$9,850 $1.97 p/Share	5,000 Added 2.04%	239,518 Common Stock
Apr 21 2022	BUY Open market or private purchase	$10,350 $2.3 p/Share	4,500 Added 1.88%	234,518 Common Stock
Apr 08 2022	BUY Open market or private purchase	$5,000 $2.5 p/Share	2,000 Added 0.88%	226,518 Common Stock
Mar 30 2022	BUY Open market or private purchase	$10,800 $2.7 p/Share	4,000 Added 1.75%	224,518 Common Stock
Mar 21 2022	BUY Open market or private purchase	$2,940 $2.45 p/Share	1,200 Added 0.54%	220,518 Common Stock
Nov 19 2021	BUY Open market or private purchase	$9,870 $2.82 p/Share	3,500 Added 1.57%	219,318 Common Stock

Also insider at

FDMT

4D Molecular Therapeutics, Inc. Healthcare

ONCT

Oncternal Therapeutics, Inc. Healthcare

Charles Theuer

PRESIDENT AND CEO

San Diego, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells TCON shares.

Notify only if

Value

Insider Trading

Get notified when an Tracon Pharmaceuticals, Inc. insider buys or sells TCON shares.

Notify only if

Operation

Value

Type

News

Receive news related to Tracon Pharmaceuticals, Inc.

Track Activities on TCON

Account